AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
AnGes Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2011 | -0.2843M |
| September 30, 2011 | 0.4183M |
| June 30, 2011 | 9.779M |
| March 31, 2011 | -0.2776M |
| December 31, 2010 | -5.913M |
| September 30, 2010 | -0.062M |
| Date | Value |
|---|---|
| June 30, 2010 | 5.989M |
| March 31, 2010 | 10.79M |
| December 31, 2009 | -5.498M |
| September 30, 2009 | -8.102M |
| June 30, 2009 | 1.644M |
| March 31, 2009 | 6.282M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | -489.35M |
| Nxera Pharma Co Ltd | -0.3369M |
| PeptiDream Inc | 70.04M |
| Healios KK | -2.480M |
| SanBio Co Ltd | -- |